LU92900I2 - Gardasil-9/vaccination contre les stéréotypes 16,18 et 31 nom de produit: hpv l1 vlps 16+18+31 - Google Patents

Gardasil-9/vaccination contre les stéréotypes 16,18 et 31 nom de produit: hpv l1 vlps 16+18+31 Download PDF

Info

Publication number
LU92900I2
LU92900I2 LU92900C LU92900C LU92900I2 LU 92900 I2 LU92900 I2 LU 92900I2 LU 92900 C LU92900 C LU 92900C LU 92900 C LU92900 C LU 92900C LU 92900 I2 LU92900 I2 LU 92900I2
Authority
LU
Luxembourg
Prior art keywords
gardasil
stereotypes
vlps
hpv
product name
Prior art date
Application number
LU92900C
Other languages
English (en)
French (fr)
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0413510.9A external-priority patent/GB0413510D0/en
Priority claimed from US11/114,301 external-priority patent/US20050287161A1/en
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of LU92900I2 publication Critical patent/LU92900I2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
LU92900C 2004-06-16 2015-12-08 Gardasil-9/vaccination contre les stéréotypes 16,18 et 31 nom de produit: hpv l1 vlps 16+18+31 LU92900I2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0413510.9A GB0413510D0 (en) 2004-06-16 2004-06-16 Vaccine
US11/114,301 US20050287161A1 (en) 2002-12-20 2005-04-26 Vaccine
PCT/EP2005/006461 WO2005123125A1 (en) 2004-06-16 2005-06-14 Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52

Publications (1)

Publication Number Publication Date
LU92900I2 true LU92900I2 (fr) 2016-03-08

Family

ID=35160037

Family Applications (3)

Application Number Title Priority Date Filing Date
LU92898C LU92898I2 (fr) 2004-06-16 2015-12-08 Gardasil-9/vaccination contre les stéréotypes 16,18 et 31 nom de produit: hpv l1 vlps 16+18+31
LU92899C LU92899I2 (fr) 2004-06-16 2015-12-08 Gardasil-9/vaccination contre les stéréotypes 16,18 et 31 nom de produit: hpv l1 vlps 16+18+31
LU92900C LU92900I2 (fr) 2004-06-16 2015-12-08 Gardasil-9/vaccination contre les stéréotypes 16,18 et 31 nom de produit: hpv l1 vlps 16+18+31

Family Applications Before (2)

Application Number Title Priority Date Filing Date
LU92898C LU92898I2 (fr) 2004-06-16 2015-12-08 Gardasil-9/vaccination contre les stéréotypes 16,18 et 31 nom de produit: hpv l1 vlps 16+18+31
LU92899C LU92899I2 (fr) 2004-06-16 2015-12-08 Gardasil-9/vaccination contre les stéréotypes 16,18 et 31 nom de produit: hpv l1 vlps 16+18+31

Country Status (18)

Country Link
EP (1) EP1758609B1 (xx)
JP (1) JP2008502633A (xx)
KR (1) KR20070029254A (xx)
AR (1) AR049354A1 (xx)
AU (1) AU2005253723B2 (xx)
BR (1) BRPI0512042B8 (xx)
CA (1) CA2566620C (xx)
FR (2) FR15C0084I2 (xx)
IL (1) IL179138A0 (xx)
LU (3) LU92898I2 (xx)
MA (1) MA28692B1 (xx)
MX (1) MXPA06014515A (xx)
NO (1) NO20070195L (xx)
PE (1) PE20060434A1 (xx)
PL (1) PL1758609T3 (xx)
RU (1) RU2420313C2 (xx)
SG (1) SG153837A1 (xx)
WO (1) WO2005123125A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008539182A (ja) * 2005-04-26 2008-11-13 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
RS53607B1 (en) * 2008-07-31 2015-04-30 Glaxosmithkline Biologicals S.A. HPV vaccine
PL2444103T3 (pl) * 2009-06-19 2018-05-30 Eyegene Inc. Szczepionka przeciwko rakowi szyjki macicy
RU2013106498A (ru) * 2010-07-15 2014-08-20 Бритиш Коламбиа Кэнсер Эйдженси Бранч Антигенные композиции папилломавируса человека е7 и их применение
WO2014068001A1 (en) 2012-10-30 2014-05-08 Redbiotec Ag Recombinant particle based vaccines against human cytomegalovirus infection
BR112017008280A2 (pt) * 2014-10-24 2018-01-02 Hpvvax, Llc. método para o tratamento de um paciente
CN107188966B (zh) 2016-03-15 2020-03-31 中国医学科学院基础医学研究所 一种乳头瘤病毒嵌合蛋白及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9921146D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
GB9921147D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
US6908613B2 (en) * 2000-06-21 2005-06-21 Medimmune, Inc. Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
GB0110431D0 (en) * 2001-04-27 2001-06-20 Glaxosmithkline Biolog Sa Novel compounds
GB0206359D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
GB0206360D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
US20060251676A1 (en) * 2002-12-20 2006-11-09 Gary Dubin Hpv-16 and-18 l1 vlp vaccine

Also Published As

Publication number Publication date
PL1758609T3 (pl) 2013-02-28
RU2420313C2 (ru) 2011-06-10
LU92898I2 (fr) 2016-03-08
PE20060434A1 (es) 2006-06-08
MA28692B1 (fr) 2007-06-01
FR15C0084I2 (fr) 2016-10-28
FR15C0084I1 (xx) 2016-01-08
LU92899I2 (fr) 2016-03-08
BRPI0512042A (pt) 2008-02-06
CA2566620A1 (en) 2005-12-29
AU2005253723B2 (en) 2011-01-20
AR049354A1 (es) 2006-07-19
BRPI0512042B1 (pt) 2019-01-22
KR20070029254A (ko) 2007-03-13
NO20070195L (no) 2007-01-15
AU2005253723A1 (en) 2005-12-29
FR15C0082I2 (fr) 2016-10-28
EP1758609A1 (en) 2007-03-07
CA2566620C (en) 2014-03-11
JP2008502633A (ja) 2008-01-31
MXPA06014515A (es) 2007-03-23
EP1758609B1 (en) 2012-10-03
IL179138A0 (en) 2007-03-08
SG153837A1 (en) 2009-07-29
RU2006143804A (ru) 2008-08-20
WO2005123125A1 (en) 2005-12-29
FR15C0082I1 (fr) 2016-01-08
BRPI0512042B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
LU92900I2 (fr) Gardasil-9/vaccination contre les stéréotypes 16,18 et 31 nom de produit: hpv l1 vlps 16+18+31
NO2017005I1 (no) Human pappilomavirus vaksine [type 6, 11, 16, 18, 31, 33, 45, 52, 58]
LU92902I2 (fr) Gardasil-9/nom du produit: protéine hpv 45 l1
LU92901I2 (fr) Gardasil-9/ nom du produit: protéine hpv58l1
GB0412181D0 (en) Biological products
GB0425569D0 (en) Biological products
TWI365866B (en) Amide derivatives, process for preparation thereof and use thereof as insecticide
ATE435880T1 (de) Verbesserte kautschukmodifizierte monovinyliden- aromapolymere und daraus hergestellte erzeugnisse
ZA200703609B (en) Semi-Soft C-Class Immunostimulatory oligonucleotides
IL189329A0 (en) Vaccination against dengue virus infection
PL2094849T3 (pl) Długotrwała zmiana przebiegu choroby z zastosowaniem oligonukleotydów immunostymulujących
FR2877842B1 (fr) Produit aerosol anti-transpirant
EP2167083A4 (en) NOVEL HETEROARYL-3-AZABICYCLOÝ3.1.0HEXANES, THEIR METHODS OF PREPARATION AND THEIR USE AS MEDICAMENTS
ATE405326T1 (de) Kosmetiktuchprodukt
GB0520169D0 (en) Biological products
GB2411205B (en) Disposable products
GB0506912D0 (en) Biological products
ITTO20060175U1 (it) Espositore, particolarmente adatto per prodotti dolciari.
ZA200802176B (en) Vaccination against dengue virus infection
FI20031065A0 (fi) Hyönteissuoja-aine, menetelmä sen valmistamiseksi ja sen käyttö
FR2859212B1 (fr) Fluxant, solumere et composition bitumineuse en contenant, preparation et application de ces produits
ITFI20080009A1 (it) "confezione per prodotti in carta tissue, per carta igienica od altro"
PL1889595T3 (pl) Wyrób do oczyszczania i/lub pielęgnacji skóry oraz sposób wytwarzania wspomnianego wyrobu
EP1935277A4 (en) HYGIENE SEAL FOR ONEWAY COMES
ITRM20040509A1 (it) Procedimento di ingobbio per caramiche e prodotto derivato.